Top

Addiction Science & Clinical Practice

Published in:

Open Access 01-12-2018 | Research

Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach

Authors: Amanda M. Bunting, Carrie B. Oser, Michele Staton, Katherine S. Eddens, Hannah Knudsen

Published in: Addiction Science & Clinical Practice | Issue 1/2018

Abstract

Background

The non-medical use of opioids has reached epidemic levels nationwide, and rural areas have been particularly affected by increasing rates of overdose mortality as well as increases in the prison population. Individuals with opioid use disorder (OUD) are at increased risk for relapse and overdose upon reentry to the community due to decreased tolerance during incarceration. It is crucial to identify barriers to substance use disorder treatment post-release from prison because treatment can be particularly difficult to access in resource-limited rural Appalachia.

Methods

A social ecological framework was utilized to examine barriers to community-based substance use treatment among individuals with OUD in Appalachian Kentucky following release from prison. Semi-structured qualitative interviews with 15 social service clinicians (SSCs) employed by the Department of Corrections were conducted to identify barriers at the individual, interpersonal, organizational/institutional level, community, and systems levels. Two independent coders conducted line-by-line coding to identify key themes.

Results

Treatment barriers were identified across the social ecological spectrum. At the individual-level, SSCs highlighted high-risk drug use and a lack of motivation. At the interpersonal level, homogenous social networks (i.e., homophilious drug-using networks) and networks with limited treatment knowledge inhibited treatment. SSC’s high case load and probation/parole officer’s limited understanding of treatment were organizational/institutional barriers. Easy access to opioids, few treatment resources, and a lack of community support for treatment were barriers at the community level. SSC’s noted system-level barriers such as lack of transportation options, cost, and uncertainty about the implementation of the Affordable Care Act.

Conclusions

More rural infrastructure resources as well as additional education for family networks, corrections staff, and the community at large in Appalachia are needed to address barriers to OUD treatment. Future research should examine barriers from the perspective of other key stakeholders (e.g., clients, families of clients) and test interventions to increase access to OUD treatment.

Martins SS, Segura LE, Santaella-Tenorio J, et al. Prescription opioid use disorder and heroin use among 12–34 year-olds in the United States from 2002 to 2014. Addict Behav. 2017;65:236–41. https://doi.org/10.1016/j.addbeh.2016.08.033.CrossRefPubMed

Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001–2002 to 2012–2013 national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2017;74(5):445–55. https://doi.org/10.1001/jamapsychiatry.2017.0113.CrossRefPubMedPubMedCentral

Welty LJ, Harrison AJ, Abram KM, et al. Health disparities in drug- and alcohol-use disorders: a 12-year longitudinal study of youths after detention. Am J Public Health. 2016;106(5):872–80. https://doi.org/10.2105/AJPH.2015.303032.CrossRefPubMedPubMedCentral

Cai R, Crane E, Poneleit K, Paulozzi L. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004–2008. J Pain Palliat Care Pharmacother. 2010;24(3):293–7. https://doi.org/10.3109/15360288.2010.503730.CrossRefPubMed

Van Handel MM, Rose CE, Hallisey EJ, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr 1999. 2016;73(3):323–31. https://doi.org/10.1097/QAI.0000000000001098.CrossRef

Florence CS, Zhou C, Luo F, Xu L. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care. 2016;54(10):901. https://doi.org/10.1097/MLR.0000000000000625.CrossRefPubMedPubMedCentral

Economic Toll of Opioid Crisis in U.S. Exceeded $1 Trillion Since 2001. Altarum. https://altarum.org/about/news-and-events/economic-toll-of-opioid-crisis-in-u-s-exceeded-1-trillion-since-2001. Published February 2, 2018. Accessed 16 May 2018.

Winkelman TNA, Chang VW, Binswanger IA. Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open. 2018;1(3):e180558. https://doi.org/10.1001/jamanetworkopen.2018.0558.CrossRefPubMedPubMedCentral

Keyes KM, Cerdá M, Brady JE, Havens JR, Galea S. Understanding the rural–urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health. 2014;104(2):e52–9. https://doi.org/10.2105/AJPH.2013.301709.CrossRefPubMedPubMedCentral

10.

Rudd RA. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016. https://doi.org/10.15585/mmwr.mm655051e1.CrossRefPubMed

11.

Moody LN, Satterwhite E, Bickel WK. Substance use in rural Central Appalachia: current status and treatment considerations. J Rural Ment Health. 2017;41(2):123–35. https://doi.org/10.1037/rmh0000064.CrossRef

12.

Havens JR, Walker R, Leukefeld CG. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend. 2007;87(1):98–102. https://doi.org/10.1016/j.drugalcdep.2006.07.008.CrossRefPubMed

13.

The Appalachian Region—Appalachian Regional Commission. https://www.arc.gov/appalachian_region/TheAppalachianRegion.asp. Accessed 28 May 2018.

14.

Sigmon SC. Access to treatment for opioid dependence in rural America: challenges and future directions. JAMA Psychiatry. 2014;71(4):359–60. https://doi.org/10.1001/jamapsychiatry.2013.4450.CrossRefPubMed

15.

Quest TL, Merrill JO, Roll J, Saxon AJ, Rosenblatt RA. Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters. J Opioid Manag. 2012;8(1):29–38.CrossRefPubMedPubMedCentral

16.

Rigg KK, Monnat SM, Chavez MN. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy. 2018;57:119–29. https://doi.org/10.1016/j.drugpo.2018.04.011.CrossRefPubMed

17.

Arcury TA, Preisser JS, Gesler WM, Powers JM. Access to transportation and health care utilization in a rural region. J Rural Health. 2005;21(1):31–8. https://doi.org/10.1111/j.1748-0361.2005.tb00059.x.CrossRefPubMed

18.

Elliott BA, Larson JT. Adolescents in mid-sized and rural communities: foregone care, perceived barriers, and risk factors. J Adolesc Health. 2004;35(4):303–9. https://doi.org/10.1016/j.jadohealth.2003.09.015.CrossRefPubMed

19.

Pullen E, Oser C. Barriers to substance abuse treatment in rural and urban communities: counselor perspectives. Subst Use Misuse. 2014;49(7):891–901. https://doi.org/10.3109/10826084.2014.891615.CrossRefPubMedPubMedCentral

20.

Sexton RL, Carlson RG, Leukefeld CG, Booth BM. Barriers to formal drug abuse treatment in the rural south: a preliminary ethnographic assessment. J Psychoact Drugs. 2008;40(2):121–9. https://doi.org/10.1080/02791072.2008.10400621.CrossRef

21.

Sung H-E, Mahoney AM, Mellow J. Substance abuse treatment gap among adult parolees: prevalence, correlates, and barriers. Crim Justice Rev. 2011;36(1):40–57. https://doi.org/10.1177/0734016810389808.CrossRef

22.

Binswanger IA, Nowels C, Corsi KF, et al. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012;7(1):3. https://doi.org/10.1186/1940-0640-7-3.CrossRefPubMedPubMedCentral

23.

Office of National Drug Control Policy. 2013 Annual Report, Arrestee Drug Monitoring Program II.

24.

Bronson J, Stropp J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009. Washington, DC: US Department of Justice; 2017.

25.

Hammersley R, Forsyth A, Morrison V, Davies JB. The relationship between crime and opioid use. Br J Addict. 1989;84(9):1029–43.CrossRefPubMed

26.

Belenko S, Hiller M, Hamilton L. Treating substance use disorders in the criminal justice system. Curr Psychiatry Rep. 2013;15(11):414. https://doi.org/10.1007/s11920-013-0414-z.CrossRefPubMed

27.

Krebs E, Urada D, Evans E, Huang D, Hser Y-I, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addict Abingdon Engl. 2017;112(5):838–51. https://doi.org/10.1111/add.13729.CrossRef

28.

Kopak AM, Lawson SW, Hoffmann NG. Criminal justice contact and relapse among patients seeking treatment for opioid use disorder. J Drug Issues. 2018;48(1):134–47. https://doi.org/10.1177/0022042617740911.CrossRef

29.

Binswanger IA, Stern MF, Deyo RA, et al. Release from prison—a high risk of death for former inmates. N Engl J Med. 2007;356(2):157–65. https://doi.org/10.1056/NEJMsa064115.CrossRefPubMedPubMedCentral

30.

Prendergast ML. Interventions to promote successful re-entry among drug-abusing parolees. Addict Sci Clin Pract. 2009;5(1):4–13.CrossRefPubMedPubMedCentral

31.

Brinkley-Rubinstein L, Rosen DL, Christopher P, Bazerman L, Beckwith CG. Long-acting injectable antiretroviral therapy: an opportunity to improve human immunodeficiency virus (HIV) treatment and reduce HIV transmission among persons being released from prison facilities. Clin Infect Dis. 2017;65(7):1247–8. https://doi.org/10.1093/cid/cix493.CrossRefPubMedPubMedCentral

32.

Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse. 2004;30(1):129–53.CrossRefPubMed

33.

Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, et al. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abuse. 2012;33(1):9–18. https://doi.org/10.1080/08897077.2011.611460.CrossRef

34.

Roberts LW, Battaglia J, Epstein RS. Frontier ethics: mental health care needs and ethical dilemmas in rural communities. Psychiatr Serv. 1999;50(4):497–503. https://doi.org/10.1176/ps.50.4.497.CrossRefPubMed

35.

Oser CB, Leukefeld CG, Staton Tindall M, et al. Rural drug users: factors associated with substance abuse treatment utilization. Int J Offender Ther Comp Criminol. 2011;55(4):567–86. https://doi.org/10.1177/0306624X10366012.CrossRefPubMed

36.

Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32(7):513–31.CrossRef

37.

McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351–77. https://doi.org/10.1177/109019818801500401.CrossRefPubMed

38.

Golden SD, Earp JAL. Social ecological approaches to individuals and their contexts: twenty years of health education & behavior health promotion interventions. Health Educ Behav. 2012;39(3):364–72. https://doi.org/10.1177/1090198111418634.CrossRefPubMed

39.

Counties in Appalachia—Appalachian Regional Commission. https://www.arc.gov/appalachian_region/CountiesinAppalachia.asp. Accessed 28 May 2018.

40.

Boyatzis RE. Transforming qualitative information: thematic analysis and code development. Thousand Oaks: SAGE; 1998.

41.

McPherson M, Smith-Lovin L, Cook JM. Birds of a feather: homophily in social networks. Annu Rev Sociol. 2001;27(1):415–44. https://doi.org/10.1146/annurev.soc.27.1.415.CrossRef

42.

Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002;186(11):1558–64. https://doi.org/10.1086/345554.CrossRefPubMed

43.

Hagan H, Pouget ER, Williams IT, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis. 2010;201(3):378–85. https://doi.org/10.1086/649783.CrossRefPubMed

44.

McCoy C, Metsch L, Chitwood D, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6–7):789.CrossRefPubMed

45.

Chipp C, Dewane S, Brems C, Johnson ME, Warner TD, Roberts LW. “If only someone had told me …”: lessons from rural providers. J Rural Health. 2011;27(1):122–30. https://doi.org/10.1111/j.1748-0361.2010.00314.x.CrossRefPubMedPubMedCentral

46.

Jonas AB, Young AM, Oser CB, Leukefeld CG, Havens JR. OxyContin^® as currency: OxyContin^® use and increased social capital among rural Appalachian drug users. Soc Sci Med. 2012;74(10):1602–9. https://doi.org/10.1016/j.socscimed.2011.12.053.CrossRefPubMedPubMedCentral

47.

Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ i ever said came true”: transitions from opioid pills to heroin injecting. Int J Drug Policy. 2014;25(2):257–66. https://doi.org/10.1016/j.drugpo.2013.10.004.CrossRefPubMed

48.

Muhuri PK, Gfroerer JC, Davies C. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review SAMHSA; 2013. p. 1–17.

49.

Mukamal DA, Samuels PN. Statutory limitations on civil rights of people with criminal records. Fordham Urb LJ. 2002;30:20.

50.

Benavides-Vaello S, Strode A, Sheeran BC. Using technology in the delivery of mental health and substance abuse treatment in rural communities: a review. J Behav Health Serv Res. 2013;40(1):111–20. https://doi.org/10.1007/s11414-012-9299-6.CrossRefPubMed

51.

Antonisse L, Garfield R, Mar 28 SAP, 2018. The effects of medicaid expansion under the ACA: updated findings from a literature review. Henry J Kais Fam Found. 2018. https://www.kff.org/medicaid/issue-brief/the-effects-of-medicaid-expansion-under-the-aca-updated-findings-from-a-literature-review-March-2018/. Accessed 14 May 2018.

52.

Foutz J, Artiga S, Apr 25 RGP, 2017. The role of medicaid in rural America. Henry J Kais Fam Found. 2017. https://www.kff.org/medicaid/issue-brief/the-role-of-medicaid-in-rural-america/. Accessed 14 May 2018.

53.

Soni A, Hendryx M, Simon K. Medicaid expansion under the affordable care act and insurance coverage in rural and urban areas. J Rural Health. 2017;33(2):217–26. https://doi.org/10.1111/jrh.12234.CrossRefPubMed

Title: Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach
Authors: Amanda M. Bunting
Carrie B. Oser
Michele Staton
Katherine S. Eddens
Hannah Knudsen
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Addiction Science & Clinical Practice / Issue 1/2018
Electronic ISSN: 1940-0640
DOI: https://doi.org/10.1186/s13722-018-0124-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Insights from individuals successfully recovered from cannabis use disorder: natural versus treatment-assisted recoveries and abstinent versus moderation outcomes

How do people with mood and anxiety disorders perceive and interpret the Drinking Motives Questionnaire? A think-aloud study in a clinical setting

Evaluation of the effect of methamphetamine on traumatic injury complications and outcomes

Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol

Study protocol testing toolkit versus usual care for implementation of screening, brief intervention, referral to treatment in hospitals: a phased cluster randomized approach

The SUMMIT ambulatory-ICU primary care model for medically and socially complex patients in an urban federally qualified health center: study design and rationale